Delivery Order SPE2DB20D3103-SPE2DB23FM3F1

Award Date 1/31/23
Potential Completion Date 2/1/23
Potential Value $2.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of a pharmaceutical product, specifically 4564490684 - FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML. The award has a ceiling value of $1,188.42 and was issued as a Delivery Order under a Firm Fixed Price contract. The contracting agency is the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government...
This federal contract award, valued at $2,154.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4,563,310,550 units of omeprazole delayed-release 40 mg capsules. The contract has an ultimate completion date of January 12, 2024 and is a firm fixed-price delivery order. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award is for the delivery of 4,564,083,797 capsules of Omeprazole DR 20 mg to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,822.24 and a period of performance through March 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order, worth $1,282.44, is for the pharmaceutical product Omeprz 2mg/ml 150ml 1s. The order has a firm fixed price pricing type and a completion date of January 17, 2023. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation used. This order is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,785.78, is for the delivery of 4566711736 - OMEPRAZ 2.5MG SUSP 30S, a generic pharmaceutical product. This award is a part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML, with a potential value of $1,013.28 and a completion date of January 8, 2024. The contract has no set-aside designation. As a prime contractor, Amerisourcebergen Drug Corp has experience supplying...
This federal contract award, valued at $2,378.21, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,330.80 firm fixed price delivery order is for the supply of 100 count capsules of 40 mg Omeprazole DR, a medication used for gastric conditions. The award has an ultimate completion date of October 31, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,609.40 delivery order contract is for the supply of 4563222653 Omeprazole DR 40 MG Capsule in 1000s to support the DLA's medical supply chain. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as a primary vehicle for the company...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FM3F1
    Delivery Order

This federal contract award, valued at $2,565.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4559786379 - FIRST-OMEPRAZOLE 2 MG/ML SUSP 300ML, a pharmaceutical product, with a completion date of February 1, 2023.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award is likely a delivery order under that larger IDC mechanism. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:18 PM